Paul Benn

766 total citations
7 papers, 62 citations indexed

About

Paul Benn is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Paul Benn has authored 7 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Paul Benn's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (3 papers) and HIV/AIDS Research and Interventions (3 papers). Paul Benn is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (3 papers) and HIV/AIDS Research and Interventions (3 papers). Paul Benn collaborates with scholars based in United Kingdom, United States and Zimbabwe. Paul Benn's co-authors include Kelong Han, Mark A. Marzinke, Parul Patel, William Spreen, Mark Lovern, Raphael J. Landovitz, Ronald D’Amico, Amy Cutrell, Susan L. Ford and Yuan Xiong and has published in prestigious journals such as British Journal of Clinical Pharmacology, HIV Medicine and International Journal of STD & AIDS.

In The Last Decade

Paul Benn

7 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Benn United Kingdom	4	49	32	21	16	12	7	62
Francisco Homar Spain	6	41 0.8×	24 0.8×	19 0.9×	26 1.6×	5 0.4×	14	88
David Dorey Canada	6	112 2.3×	74 2.3×	19 0.9×	43 2.7×	5 0.4×	10	156
Tanaka Muzenda United States	2	82 1.7×	70 2.2×	38 1.8×	25 1.6×	4 0.3×	2	102
Bernard Kikaire Uganda	6	57 1.2×	42 1.3×	9 0.4×	14 0.9×	15 1.3×	15	87
Jacqueline Voget South Africa	4	78 1.6×	18 0.6×	12 0.6×	36 2.3×	14 1.2×	8	89
Pascale Fialaire France	5	42 0.9×	24 0.8×	21 1.0×	13 0.8×	5 0.4×	9	50
Dorothy Sichali United States	4	56 1.1×	16 0.5×	14 0.7×	32 2.0×	9 0.8×	4	62
Ahmed Ddungu Uganda	5	63 1.3×	26 0.8×	56 2.7×	16 1.0×	4 0.3×	6	93
Godson Oguchi United States	3	122 2.5×	84 2.6×	62 3.0×	11 0.7×	12 1.0×	5	125
Patricia Nahirya Ntege Uganda	3	71 1.4×	42 1.3×	39 1.9×	22 1.4×	7 0.6×	5	102

Countries citing papers authored by Paul Benn

Since Specialization

Citations

This map shows the geographic impact of Paul Benn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Benn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Benn more than expected).

Fields of papers citing papers by Paul Benn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Benn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Benn. The network helps show where Paul Benn may publish in the future.

Co-authorship network of co-authors of Paul Benn

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Benn. A scholar is included among the top collaborators of Paul Benn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Benn. Paul Benn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Han, Kelong, Paul Benn, Jörg Sievers, et al.. (2025). A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV. Clinical Pharmacology in Drug Development. 14(7). 528–541. 1 indexed citations

Benn, Paul, Ying Zhang, Lesley Kahl, et al.. (2023). A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937. Pharmacology Research & Perspectives. 11(3). e01093–e01093. 7 indexed citations

Han, Kelong, Mark Baker, Mark Lovern, et al.. (2022). Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects. British Journal of Clinical Pharmacology. 88(10). 4607–4622. 32 indexed citations

Okoli, Chinyere, Achim Schwenk, Stephen Taylor, et al.. (2021). Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens. International Journal of STD & AIDS. 32(12). 1165–1173. 1 indexed citations

D’Amico, Ronald, Paul Benn, Cynthia McCoig, et al.. (2020). LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials. Open Forum Infectious Diseases. 7(Supplement_1). S847–S848. 2 indexed citations

Okoli, Chinyere, Achim Schwenk, Stephen Taylor, et al.. (2020). Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database. HIV Medicine. 21(8). 471–480. 13 indexed citations

Benn, Paul, Robert F. Miller, Linda Evans, Jane Minton, & Simon Edwards. (2009). Devolving of statin prescribing to general practitioners for HIV-infected patients receiving antiretroviral therapy. International Journal of STD & AIDS. 20(3). 202–204. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact